Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $63,188 | 11 | 99.2% |
| Food and Beverage | $479.57 | 16 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $63,188 | 11 | $0 (2021) |
| Dendreon Pharmaceuticals LLC | $128.05 | 3 | $0 (2018) |
| Janssen Scientific Affairs, LLC | $121.72 | 1 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $55.51 | 2 | $0 (2023) |
| Ferring Pharmaceuticals Inc. | $34.20 | 2 | $0 (2024) |
| Amniox Medical, Inc. | $32.40 | 1 | $0 (2018) |
| MEDIVATION FIELD SOLUTIONS LLC | $31.39 | 2 | $0 (2018) |
| PFIZER INC. | $31.15 | 2 | $0 (2024) |
| Verity Pharmaceuticals Inc. | $29.71 | 2 | $0 (2023) |
| Mission Pharmacal Company | $15.44 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $65.35 | 4 | Ferring Pharmaceuticals Inc. ($34.20) |
| 2023 | $69.12 | 3 | Sumitomo Pharma America, Inc. ($55.51) |
| 2022 | $137.82 | 2 | Janssen Scientific Affairs, LLC ($121.72) |
| 2021 | $24,813 | 4 | E.R. Squibb & Sons, L.L.C. ($24,813) |
| 2020 | $38,375 | 7 | E.R. Squibb & Sons, L.L.C. ($38,375) |
| 2018 | $191.84 | 6 | Dendreon Pharmaceuticals LLC ($128.05) |
| 2017 | $15.44 | 1 | Mission Pharmacal Company ($15.44) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: ONCOLOGY | ||||||
| 09/30/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: ONCOLOGY | ||||||
| 04/25/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: HORMONE THERAPY | ||||||
| 04/24/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $27.92 | General |
| Category: HORMONE THERAPY | ||||||
| 04/03/2023 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $13.61 | General |
| Category: Prostate cancer | ||||||
| 11/29/2022 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $121.72 | General |
| Category: Oncology | ||||||
| 10/24/2022 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $16.10 | General |
| Category: Prostate cancer | ||||||
| 02/25/2021 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| 02/18/2021 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $5,625.00 | General |
| 02/01/2021 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $5,625.00 | General |
| 01/14/2021 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $9,562.50 | General |
| 12/30/2020 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $4,125.00 | General |
| 12/16/2020 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $6,625.00 | General |
| 12/02/2020 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $3,750.00 | General |
| 11/19/2020 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $6,187.50 | General |
| 11/06/2020 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $8,187.50 | General |
| 10/07/2020 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $6,125.00 | General |
| 09/21/2020 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $3,375.00 | General |
| 11/27/2018 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $72.90 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/08/2018 | Amniox Medical, Inc. | NEOX (Biological), CLARIX | Food and Beverage | Cash or cash equivalent | $32.40 | General |
| Category: Human Tissue Products | ||||||
| 09/30/2018 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 06/18/2018 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $34.71 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 05/02/2018 | MEDIVATION FIELD SOLUTIONS LLC | XTANDI (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: ONCOLOGY | ||||||
About Dr. Lee Schacter, M.D
Dr. Lee Schacter, M.D is a Hematology & Oncology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285725796.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lee Schacter, M.D has received a total of $63,667 in payments from pharmaceutical and medical device companies, with $65.35 received in 2024. These payments were reported across 27 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($63,188).
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Philadelphia, PA
- Active Since 09/28/2006
- Last Updated 09/11/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1285725796
Products in Payments
- PROVENGE (Drug) $128.05
- ERLEADA (Drug) $121.72
- XTANDI (Drug) $62.54
- ORGOVYX (Drug) $55.51
- ADSTILADRIN (Biological) $34.20
- NEOX (Biological) $32.40
- Trelstar (Drug) $29.71
- Uribel (Drug) $15.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Philadelphia
Shayma Kazmi, Md, MD
Hematology & Oncology — Payments: $715,210
Charu Aggarwal, Md, Mph, MD, MPH
Hematology & Oncology — Payments: $510,275
Dr. Catherine Lai, M.d., M.p.h, M.D., M.P.H
Hematology & Oncology — Payments: $249,951
Dr. Martin Edelman, M.d, M.D
Hematology & Oncology — Payments: $207,464
Keith Pratz, M.d, M.D
Hematology & Oncology — Payments: $175,955
David Porter, Md, MD
Hematology & Oncology — Payments: $173,636